A study presented at the Heart Rhythm Society meeting analyzed the use of the CHA2DS2-VASc stroke risk calculator in distinguishing patients with subclinical atrial fibrillation who would benefit from anticoagulation. Results showed that patients with a CHA2DS2-VASc score of 4 or above had a significant risk of stroke but could benefit from anticoagulation. The study emphasized the importance of using clinical risk factors in decision-making rather than focusing solely on arrhythmia burden. However, results from another trial presented at the meeting showed conflicting findings, highlighting the need for shared clinical decision-making when considering anticoagulation for atrial fibrillation.
Source link
Stroke Risk Scale Helps ID Candidates for Anticoagulation
